These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 18434631

  • 1. Response evaluation of gastrointestinal stromal tumors.
    Choi H.
    Oncologist; 2008; 13 Suppl 2():4-7. PubMed ID: 18434631
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The lessons of GIST--PET and PET/CT: a new paradigm for imaging.
    Van den Abbeele AD.
    Oncologist; 2008; 13 Suppl 2():8-13. PubMed ID: 18434632
    [Abstract] [Full Text] [Related]

  • 4. CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings.
    Choi H, Charnsangavej C, de Castro Faria S, Tamm EP, Benjamin RS, Johnson MM, Macapinlac HA, Podoloff DA.
    AJR Am J Roentgenol; 2004 Dec; 183(6):1619-28. PubMed ID: 15547201
    [Abstract] [Full Text] [Related]

  • 5. Imaging of gastrointestinal stromal tumors before and after imatinib mesylate therapy.
    Shankar S, Dundamadappa SK, Karam AR, Stay RM, van Sonnenberg E.
    Acta Radiol; 2009 Oct; 50(8):837-44. PubMed ID: 19735005
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Highlighting the role of FDG PET scan in early response assessment of gastrointestinal stromal tumor treated with imatinib mesylate.
    Abhyankar SA, Nair N.
    Clin Nucl Med; 2008 Mar; 33(3):213-4. PubMed ID: 18287851
    [No Abstract] [Full Text] [Related]

  • 8. CT evaluation of gastrointestinal stromal tumors treated with imatinib mesylate.
    Erturk SM.
    AJR Am J Roentgenol; 2005 Nov; 185(5):1366; author reply 1366-7. PubMed ID: 16247167
    [No Abstract] [Full Text] [Related]

  • 9. Resistance to treatment in gastrointestinal stromal tumours: what radiologists should know.
    Tirumani SH, Jagannathan JP, Hornick JL, Ramaiya NH.
    Clin Radiol; 2013 Aug; 68(8):e429-37. PubMed ID: 23622797
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Very early detection of response to imatinib mesylate therapy of gastrointestinal stromal tumours using 18fluoro-deoxyglucose-positron emission tomography.
    Heinicke T, Wardelmann E, Sauerbruch T, Tschampa HJ, Glasmacher A, Palmedo H.
    Anticancer Res; 2005 Aug; 25(6C):4591-4. PubMed ID: 16334147
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Utility of FDG-PET for early evaluation of efficiency of imatinib mesylate (Glivec) in the treatment of gastrointestinal stromal tumors].
    García-González J, Sánchez Salmón A, Areses Manrique C, León Mateos L, Barandela Salgado J, López López R.
    Rev Esp Med Nucl; 2007 Aug; 26(2):100-2. PubMed ID: 17386236
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Role of FDG PET in the staging, recurrence and treatment response to imatinib (Glivec) in patients with gastrointestinal stromal tumors].
    Simó Perdigó M, García Garzón JR, Soler Peter M, Pérez Moure G, López Gandul S, Lomeña Caballero FJ.
    Rev Esp Med Nucl; 2006 Aug; 25(2):80-8. PubMed ID: 16759613
    [Abstract] [Full Text] [Related]

  • 17. PET scanning evaluation of response to imatinib mesylate therapy in gastrointestinal stromal tumor (GIST) patients.
    Gelibter A, Milella M, Ceribelli A, Zeuli M, Ferraresi V, Vecchione A, Cognetti F.
    Anticancer Res; 2004 Aug; 24(5B):3147-51. PubMed ID: 15510603
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CT and PET: early prognostic indicators of response to imatinib mesylate in patients with gastrointestinal stromal tumor.
    Holdsworth CH, Badawi RD, Manola JB, Kijewski MF, Israel DA, Demetri GD, Van den Abbeele AD.
    AJR Am J Roentgenol; 2007 Dec; 189(6):W324-30. PubMed ID: 18029844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.